Ask AI
Interpregnancy Obesity Care

CE / CME

Interactive Case Challenge 2: Interconception Obesity Management

Physician Assistants/Physician Associates: 0.50 AAPA Category 1 CME credit

Physicians: maximum of 0.50 AMA PRA Category 1 Credit

Nurse Practitioners/Nurses: 0.50 Nursing contact hour

Released: December 19, 2025

Expiration: December 18, 2026

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

After discussing treatment options with you, your patient Pat (36 years of age; G1P1) decides to add an incretin-based antiobesity medication (AOM) to her treatment plan. She also tells you that she has been diagnosed with metabolic dysfunction–associated steatotic liver disease (MASLD) and had her gallbladder removed since her last pregnancy. How should she be counseled about incretin-based AOMs?